News Quantified

ARDS – aridis pharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Aridis Provides Corporate Update

Form SC 13G/A Aridis Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC

Top News Decliners

12/30 Aridis Pharmaceuticals Inc (NASDAQ: ARDS) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -16.0%

7/30 Form 8-K Aridis Pharmaceuticals, For: Jul 26 -13.9%

6/12 Form 10-K/A Aridis Pharmaceuticals, For: Dec 31 -12.6%

7/31 Aridis Pharmaceuticals Inc (NASDAQ: ARDS) had its "buy" rating re-affirmed by analysts at Maxim Group. -10.3%

9/3 Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa -9.1%

8/14 Form 8-K Aridis Pharmaceuticals, For: Aug 13 -9.1%

9/16 Aridis Pharmaceuticals Inc (NASDAQ: ARDS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.9%

6/4 Aridis Pharmaceuticals Inc (NASDAQ: ARDS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%

10/7 Aridis Pharmaceuticals Inc (NASDAQ: ARDS) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%

6/10 Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors -6.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}